University of Eastern Piedmont
13
1
1
12
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
8%
1 of 12 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
EVALUATION OF THE TOLERABILITY AND BIOMEDICAL POTENTIAL OF A GARMENT CONTAINING PRINTED CERAMICS IN MUSCULAR PAIN
Role: collaborator
Impact of "Targeted" Nutritional Apport and Exercise on the Modulation of Metabolic and Immune-related Gene Expression Signatures in Early Breast Cancer (eBC) Patients Candidate to Neoadjuvant Therapy (NAT)
Role: lead
The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guerin on the Quality of Life in Superficial Bladder Cancer
Role: collaborator
European Quality of Care Pathways Study on Proximal Femur Fracture (EQCP-PFF)
Role: collaborator
Omega-3 and Vitamin D Supplements in Childhood T1D
Role: collaborator
Gluten-free Diet in Gluten-genetically Predisposed Subjects
Role: collaborator
Bedside Nursing Handovers in the Surgical Context
Role: lead
European Quality of Care Pathways Study on the Effect of Care Pathways on Interprofessional Teamwork (EQCP-TEAM)
Role: collaborator
European Quality of Care Pathways Study on Chronic Obstructive Pulmonary Disease (COPD)
Role: collaborator
Effectiveness of the Updated Version of the School-based Program Diario Della Salute (DDS-2)
Role: collaborator
A School-based Prevention Intervention to Promote Wellbeing in Preadolescents
Role: collaborator
Oral Peptones Load in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism and Healthy Subjects
Role: lead
Clinical Pathways for Effective and Appropriate Care
Role: collaborator
All 13 trials loaded